Yasmeen Rahimi

Yasmeen Rahimi

Company: ROTH Capital Partners

Job title: MD & Senior Research Analyst, Co-Head of Biotechnology Research


Yasmeen has been a Senior Research Analyst at ROTH since 2017, covering companies that are developing therapeutics to treat various liver diseases and conditions, including Nonalcoholic Steatohepatitis (NASH). She also covers companies that are developing products aligned in the orphan and ultra-orphan therapeutics, as well as women’s health.

Dr. Rahimi has extensive expertise in NASH and liver metabolism with 16 publications in highly prestigious journals. She trained at Yale University in the laboratory of Dr. Gerald Shulman, a world-renowned endocrinologist who pioneered the understanding of lipid-induced insulin resistance. In addition, she completed her Ph.D. training in the laboratory of Dr. Robert A. Harris, a distinguished biochemist at Indiana University.

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.